FPA154
/ Inhibrx Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 12, 2017
FPA-154: Anticipated patent expiry in US in 2036
(Five Prime Therap)
- Annual Report 2016
Anticipated patent expiry • Oncology
August 12, 2017
FPA-154: Submission of IND in 2018
(Five Prime Therap)
- Q2 FY 2017 Results
IND • Oncology
1 to 2
Of
2
Go to page
1